Geórgia A. P.
- Country
- Spain
- Department
- Oncology
Research Overview
- Evaluation of KO-2806 as Monotherapy and in Combination Therapies for Advanced Colorectal, NSCLC, Pancreatic, and Renal Cell Carcinomas
- Evaluation of YL201 in Patients with Advanced Solid Tumors: A Phase I Clinical Trial
- Phase 1b/2 Study of PF-08634404 Monotherapy and Combination Therapy in Adults with Locally Advanced or Metastatic Renal Cell Carcinoma
Data & Insights
Has run more than one trial at 84 of 211 partner sites.
Specializations
Thoracic and Solid Tumor Oncology
Clinical activity is centered on non-small cell lung cancer, small cell lung cancer, and other advanced solid malignancies, with additional involvement in breast cancer, colorectal cancer, renal cell carcinoma, urothelial carcinoma, melanoma, and head and neck squamous cell carcinoma. The portfolio also includes gastrointestinal stromal tumor, pancreatic cancer, and selected sarcomas.
- Advanced and metastatic solid tumors
- Lung cancer
- Breast and gastrointestinal cancers
- Sarcoma and melanoma
Work in this area reflects a strong therapeutic focus on treatment-resistant disease, biomarker-defined cancer subtypes, and novel antitumor strategies in oncology.
Hematologic Malignancies and Cellular Therapy
Research interests extend across multiple myeloma, acute myeloid leukemia, myelodysplastic syndromes, chronic lymphocytic leukemia, follicular lymphoma, diffuse large B-cell lymphoma, and Hodgkin lymphoma. The investigator is also involved in studies of CAR T-cell therapy, hematopoietic stem cell transplantation, and post-transplant complications.
- Plasma cell disorders
- Leukemia and myelodysplasia
- B-cell and T-cell lymphomas
- Cell therapy and transplantation
This area includes therapeutic development for relapsed and refractory blood cancers, with attention to immune-based and targeted treatment approaches.
Cardiovascular and Thrombotic Disease
Clinical research includes acute myocardial infarction, heart failure, atrial fibrillation, atherosclerotic cardiovascular disease, coronary artery disease, stroke, and venous thromboembolism. Additional interest is seen in dyslipidemia, hypertriglyceridemia, and prevention of recurrent cardiovascular events.
- Ischemic heart disease
- Arrhythmia and anticoagulation
- Stroke prevention
- Lipid disorders
The cardiovascular portfolio also includes intervention-focused work in patients with acute and chronic cardiometabolic risk.
Neurology, Psychiatry, and Neurodegeneration
Research involvement spans Alzheimer’s disease, mild cognitive impairment, Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis, epilepsy, migraine, schizophrenia, and major depressive disorder. The investigator also works in refractory status epilepticus, Huntington’s disease, and other neurocognitive and neurodegenerative conditions.
- Neurodegenerative disorders
- Seizure and epilepsy syndromes
- Movement disorders
- Psychiatric illness
Therapeutic interest is concentrated on diseases with high unmet need across cognition, behavior, and motor function.
Immune-Mediated and Inflammatory Disorders
The investigator is active in systemic lupus erythematosus, cutaneous lupus erythematosus, systemic sclerosis, rheumatoid arthritis, psoriasis, atopic dermatitis, hidradenitis suppurativa, ulcerative colitis, Crohn’s disease, and myasthenia gravis. Related work includes allergic rhinitis, urticaria, asthma, and interstitial lung disease linked to systemic autoimmune disease.
- Autoimmune rheumatic disease
- Inflammatory skin disease
- Inflammatory bowel disease
- Allergic and respiratory inflammation
This research area reflects a strong therapeutic emphasis on immune dysregulation, chronic inflammation, and organ-specific autoimmune complications.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.